{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:06Z","timestamp":1792791486155,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SGR21\/01169"],"award-info":[{"award-number":["SGR21\/01169"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["825575"],"award-info":[{"award-number":["825575"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CIVP19A5949"],"award-info":[{"award-number":["CIVP19A5949"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["LCF\/PR\/SP23\/52950009"],"award-info":[{"award-number":["LCF\/PR\/SP23\/52950009"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD21\/0017\/0012"],"award-info":[{"award-number":["RD21\/0017\/0012"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD21\/0017\/0034"],"award-info":[{"award-number":["RD21\/0017\/0034"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Ramon Areces Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-119692RB-C22"],"award-info":[{"award-number":["PID2020-119692RB-C22"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ymthe.2025.07.022","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T23:23:46Z","timestamp":1752794626000},"page":"4820-4833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic AASS inhibition by AAV-miRNA rescues glutaric aciduria type I severe phenotype in mice"],"prefix":"10.1016","volume":"33","author":[{"given":"Eul\u00e0lia","family":"Segur-Bailach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mateu-Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bofill-De Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Par\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"da Silva Buttkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Rathkolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Gailus-Durner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hrab\u011b de Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Moeini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Gonzalez-Aseguinolaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Tort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Ribes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara D.M.","family":"van Karnebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Garc\u00eda-Villoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0801-3338","authenticated-orcid":false,"given":"Cristina","family":"Fillat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.07.022_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0006-2944(75)90091-5","article-title":"Glutaric aciduria; a \u201cnew\u201d disorder of amino acid metabolism","volume":"12","author":"Goodman","year":"1975","journal-title":"Biochem. Med."},{"key":"10.1016\/j.ymthe.2025.07.022_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1203\/PDR.0b013e318137a124","article-title":"Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany","volume":"62","author":"K\u00f6lker","year":"2007","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymthe.2025.07.022_bib3","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ana.25233","article-title":"Newborn screening: A disease-changing intervention for glutaric aciduria type 1","volume":"83","author":"Boy","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2025.07.022_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ajmg.c.30088","article-title":"Glutaric acidemia type 1","volume":"142C","author":"Hedlund","year":"2006","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.ymthe.2025.07.022_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ymgme.2011.08.027","article-title":"The unsolved puzzle of neuropathogenesis in glutaric aciduria type I","volume":"104","author":"Jafari","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2025.07.022_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10545-006-0415-8","article-title":"The aetiology of neurological complications of organic acidaemias--a role for the blood-brain barrier","volume":"29","author":"K\u00f6lker","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2025.07.022_bib7","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/brain\/awp112","article-title":"Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I","volume":"132","author":"Harting","year":"2009","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2025.07.022_bib8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/jimd.12566","article-title":"Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: Third revision","volume":"46","author":"Boy","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2025.07.022_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41436-020-00971-4","article-title":"Impact of newborn screening and quality of therapy on the neurological outcome in glutaric aciduria type 1: a meta-analysis","volume":"23","author":"Boy","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2025.07.022_bib10","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jimd.12276","article-title":"Deletion of 2-aminoadipic semialdehyde synthase limits metabolite accumulation in cell and mouse models for glutaric aciduria type 1","volume":"43","author":"Leandro","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2025.07.022_bib11","doi-asserted-by":"crossref","first-page":"eadf4086","DOI":"10.1126\/scitranslmed.adf4086","article-title":"Rescue of glutaric aciduria type I in mice by liver-directed therapies","volume":"15","author":"Barzi","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.07.022_bib12","series-title":"The Lysine Degradation Pathway: Subcellular Compartmentalization and Enzyme Deficiencies","author":"Leandro","year":"2020"},{"key":"10.1016\/j.ymthe.2025.07.022_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-4939-3271-9_5","article-title":"Design of shRNA and miRNA for Delivery to the CNS","volume":"1382","author":"Toro Cabrera","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.07.022_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymeth.2016.04.003","article-title":"Guidelines for the optimal design of miRNA-based shRNAs","volume":"103","author":"Bofill-De Ros","year":"2016","journal-title":"Methods"},{"key":"10.1016\/j.ymthe.2025.07.022_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.molcel.2019.06.012","article-title":"High-Throughput Analysis Reveals Rules for Target RNA Binding and Cleavage by AGO2","volume":"75","author":"Becker","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2025.07.022_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115166","article-title":"The structural basis for RNA slicing by human Argonaute2","volume":"44","author":"Mohamed","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2025.07.022_bib17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nbt1404","article-title":"The impact of target site accessibility on the design of effective siRNAs","volume":"26","author":"Tafer","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.07.022_bib18","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.molcel.2018.07.020","article-title":"Argonaute-miRNA Complexes Silence Target mRNAs in the Nucleus of Mammalian Stem Cells","volume":"71","author":"Sarshad","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2025.07.022_bib19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/hmg\/11.4.347","article-title":"Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I","volume":"11","author":"Koeller","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.07.022_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg6618","article-title":"Primate-conserved carbonic anhydrase IV and murine-restricted LY6C1 enable blood-brain barrier crossing by engineered viral vectors","volume":"9","author":"Shay","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2025.07.022_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41434-024-00466-w","article-title":"Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles","volume":"31","author":"Bunuales","year":"2024","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.07.022_bib22","article-title":"Intravenous injections in neonatal mice","volume":"11","author":"Lampe","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymthe.2025.07.022_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101276","article-title":"Systemic delivery of AAV-GCDH ameliorates HLD-induced phenotype in a glutaric aciduria type I mouse model","volume":"32","author":"Mateu-Bosch","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.07.022_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113324","article-title":"Gene therapy clinical trials, where do we go? An overview","volume":"153","author":"Arabi","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymthe.2025.07.022_bib25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/brain\/awl009","article-title":"A diet-induced mouse model for glutaric aciduria type I","volume":"129","author":"Zinnanti","year":"2006","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2025.07.022_bib26","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1172\/JCI31617","article-title":"Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I","volume":"117","author":"Zinnanti","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.07.022_bib27","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.nutres.2008.09.010","article-title":"Protein-induced alterations in murine hepatic alpha-aminoadipate delta-semialdehyde synthase activity are mediated posttranslationally","volume":"28","author":"Kiess","year":"2008","journal-title":"Nutr. Res."},{"key":"10.1016\/j.ymthe.2025.07.022_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104467","article-title":"Acute lysine overload provokes marked striatum injury involving oxidative stress signaling pathways in glutaryl-CoA dehydrogenase deficient mice","volume":"129","author":"Amaral","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ymthe.2025.07.022_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/15476286.2015.1128062","article-title":"Quantitative evaluation of first, second, and third generation hairpin systems reveals the limit of mammalian vector-based RNAi","volume":"13","author":"Watanabe","year":"2016","journal-title":"RNA Biol."},{"key":"10.1016\/j.ymthe.2025.07.022_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molcel.2015.08.015","article-title":"The menu of features that define primary microRNAs and enable de novo design of microRNA genes","volume":"60","author":"Fang","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2025.07.022_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/15476286.2022.2025680","article-title":"Flexible pri-miRNA structures enable tunable production of 5\u2019 isomiRs","volume":"19","author":"Bofill-De Ros","year":"2022","journal-title":"RNA Biol."},{"key":"10.1016\/j.ymthe.2025.07.022_bib32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.molcel.2020.02.024","article-title":"Structural Basis for pri-miRNA Recognition by Drosha","volume":"78","author":"Jin","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2025.07.022_bib33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.molcel.2020.02.016","article-title":"Cryo-EM Structures of Human Drosha and DGCR8 in Complex with Primary MicroRNA","volume":"78","author":"Partin","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2025.07.022_bib34","article-title":"siRNA Versus miRNA as Therapeutics for Gene Silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.07.022_bib35","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.07.022_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-1-4939-3112-5_21","article-title":"Intravascular AAV9 Administration for Delivering RNA Silencing Constructs to the CNS and Periphery","volume":"1364","author":"Dufour","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.07.022_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011953","article-title":"Structural basis of the recognition of adeno-associated virus by the neurological system-related receptor carbonic anhydrase IV","volume":"20","author":"Zhang","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2025.07.022_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.07.022_bib39","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3390\/biomedicines12071523","article-title":"Recombinant Adeno-Associated Virus Vectors for Gene Therapy of the Central Nervous System: Delivery Routes and Clinical Aspects","volume":"12","author":"S\u0142yk","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymthe.2025.07.022_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nbt0109-42","article-title":"Crossing the Rubicon","volume":"27","author":"Lowenstein","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.07.022_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2014.00042","article-title":"Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse","volume":"8","author":"Schuster","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.ymthe.2025.07.022_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2019.00093","article-title":"Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation","volume":"13","author":"Haery","year":"2019","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.ymthe.2025.07.022_bib43","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0271-5317(05)80792-4","article-title":"Metabolic response of liver lysine \u03b1-ketoglutarate reductase activity in rats fed lysine limiting or lysine excessive diets","volume":"13","author":"Foster","year":"1993","journal-title":"Nutr. Res."},{"key":"10.1016\/j.ymthe.2025.07.022_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijdevneu.2019.05.005","article-title":"Pathogenesis of brain damage in glutaric acidemia type I: Lessons from the genetic mice model","volume":"78","author":"Wajner","year":"2019","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.ymthe.2025.07.022_bib45","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2019.01.009","article-title":"Ammonium accumulation and chemokine decrease in culture media of Gcdh-\/- 3D reaggregated brain cell cultures","volume":"126","author":"Cudr\u00e9-Cung","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2025.07.022_bib46","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12035-018-1077-x","article-title":"Long Lasting High Lysine Diet Aggravates White Matter Injury in Glutaryl-CoA Dehydrogenase Deficient (Gcdh-\/-) Mice","volume":"56","author":"Olivera-Bravo","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymthe.2025.07.022_bib47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.07.022_bib48","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s11064-005-7711-9","article-title":"Glutaric acid administration impairs energy metabolism in midbrain and skeletal muscle of young rats","volume":"30","author":"Ferreira","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymthe.2025.07.022_bib49","doi-asserted-by":"crossref","DOI":"10.3791\/63344","article-title":"Stereotaxic Surgical Approach to Microinject the Caudal Brainstem and Upper Cervical Spinal Cord via the Cisterna Magna in Mice","author":"Joshi","year":"2022","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymthe.2025.07.022_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/9780470942390.mo130054","article-title":"Blood Collection from Mice and Hematological Analyses on Mouse Blood","volume":"3","author":"Rathkolb","year":"2013","journal-title":"Curr. Protoc. Mouse Biol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625005581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625005581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:59Z","timestamp":1792788299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625005581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1525001625005581"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.07.022","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic AASS inhibition by AAV-miRNA rescues glutaric aciduria type I severe phenotype in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}